Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study

BACKGROUND: The aim of this study was to investigate the effectiveness and tolerability of the combination elvitegravir/cobicistat/tenofovir/emtricitabine plus darunavir (EVG/COB/TFV/FTC + DRV) in treatment-experienced patients from the cohort of the Spanish HIV/AIDS Research Network (CoRIS). METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Suárez-García, Inés, Moreno, Cristina, Ruiz-Algueró, Marta, Pérez-Elías, María Jesús, Navarro, Marta, Díez Martínez, Marcos, Viciana, Pompeyo, Pérez-Martínez, Laura, Górgolas, Miguel, Amador, Concha, de Zárraga, Miguel Alberto, Jarrín, Inma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372769/
https://www.ncbi.nlm.nih.gov/pubmed/32690099
http://dx.doi.org/10.1186/s12981-020-00302-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372769/
https://www.ncbi.nlm.nih.gov/pubmed/32690099
http://dx.doi.org/10.1186/s12981-020-00302-2

Ejemplares similares